Calls for change as access to cell and gene therapies in the Netherlands falls short
The Netherlands is falling behind other European countries in providing access to advanced therapy medicinal products (ATMPs) according to Peter…
cytiva cell & gene therapy
-
-
Takeda walks away from cell therapy in priority U-turn
Japanese pharma Takeda has pulled the plug on its cell therapy efforts, despite its strong prior focus on the modality.…
-
FDA accepts Mesoblast’s latest BLA for paediatric GvHD cell therapy
Mesoblast has announced that the US Food and Drug Administration (FDA) has accepted a resubmitted biologics license application (BLA) for…
